Optos will launch the new 200Dx Ultra-widefield Retinal Imaging system in Australia at the Optical Distributors and Manufacturers Association exhibition (ODMA) in Sydney this August.
The company’s ultra-wide field imaging technology produces high resolution digital images of approximately 82 per cent of the retina – something Optos claims no other device is capable of doing in a single image. Optos says that the 200Dx is “poised to enhance the way eye exams are conducted in Australia”.
The 200Dx captures simultaneous non-contact pole-to-periphery imaging of up to 200° of the retina in a single capture with or without mydriasis. The images provide optometrists and ophthalmologists with clinical information that facilitates the early detection, management and treatment of disorders and diseases evidenced in the retina such as retinal detachments and tears, glaucoma, diabetic retinopathy and age-related macular degeneration. Retinal imaging can also indicate evidence of non-eye or systemic diseases such as hypertension and certain cancers.
Describing the new technology, Optos says that the 200Dx offers “excellent image quality with: crisp, bright images and superior field illumination, distinct visualisation of the retinal nerve fibre layer, small vessel and macular detail, improved optic disc view and even lighting from pole to periphery.”
Integrated Software Tools in the 200Dx include 3D Wrap, education tools to assist patient interactions and comparison image overlay and auto review. According to Optos, a softer patient interface also allows for easier alignment and image capture.
